FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This is the ...

Piper Sandler raised the firm’s price target on Cytek Biosciences (CTKB) to $8.50 from $8 following quarterly results. The firm keeps an ...

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.4% growth forecast ...

William McCombe; Chief Financial Officer; Cytek Biosciences, Inc.

Cytek Biosciences, Inc. ( (CTKB) ) has released its Q3 earnings. Here is a breakdown of the information Cytek Biosciences, Inc. presented to ...

Analysts are estimating that Cytek Biosciences will report an earnings per share (EPS) of $0.00. The announcement from Cytek Biosciences is eagerly anticipated, with investors seeking news of ...

This represents an increase of $0.6 million, despite a cash expenditure of $12.1 million for the repurchase of Cytek shares during the third quarter. Cytek Biosciences reaffirms its 2024 revenue ...

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in ...

Launched SpectroPanel™ tool, a proprietary new intelligent algorithm which suggests optimized panels in minutes, expanding the capabilities of the Panel Builder tool within the Cytek® Cloud ...

Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences' Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any ...